Keywords: Genzyme, Sanofi, Fabrazyme, Fabry disease, Shipping, Framgingham, US plant

Genzyme to start shipping Fabrazyme from newly-approved plant

Article | 01 March 2012

Print This

French drug major Sanofi’s (Euronext: SAN) US subsidiary Genzyme says that it has begun shipping its Fabry disease ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in